Novel diagnostic biomarkers of T cell-mediated tumor killing characteristics for early-stage triple negative breast cancer: A SEER analysis and molecular portraits.

Chang, Qing; Fan, Liwen; Li, Mo; Liu, Linlin

Chang, Qing; Fan, Liwen; Li, Mo; Liu, Linlin.

Afiliación

Chang Q; Department of Radiotherapy, China-Japan Union Hospital of Jilin University, Changchun, China.
Fan L; Jilin Provincial Key Laboratory of Early Screening and Health Management for Cancer, China-Japan Union Hospital of Jilin University, Changchun, China.
Li M; Biotechnology and Medical Materials Engineering Research Center of Jilin Province, China-Japan Union Hospital of Jilin University, Changchun, China.
Liu L; Department of Radiotherapy, China-Japan Union Hospital of Jilin University, Changchun, China.

Medicine (Baltimore) ; 102(8): e33059, 2023 Feb 22.

Article en En | MEDLINE | ID: mdl-36827041

Asunto(s)

Neoplasias de la Mama Triple Negativas; Humanos; Persona de Mediana Edad; Neoplasias de la Mama Triple Negativas/patología; Estadificación de Neoplasias; Pronóstico; Análisis de Supervivencia; Estimación de Kaplan-Meier; Biomarcadores de Tumor; Antígenos de Neoplasias; Proteínas de la Membrana

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Humans / Middle aged Idioma: En Revista: Medicine (Baltimore) Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google